Literature DB >> 12354373

Noncompliance with Treatment of Neurologic Disease.

Jeffrey S. Nicholl1.   

Abstract

Noncompliance is a major problem in the treatment of a number of neurologic disorders. Because many neurologic disorders are chronic and many treatments are prophylactic rather than symptomatic, noncompliance is of particular concern. The fact that many neurologic disorders also affect cognition, motivation, and mood adds to this problem. Decreasing the number of times per day the patient is supposed to take the medication is the single most effective way of improving compliance. Making the patient an active participant in treatment planning, as well as through patient education, use of a pillbox, and frequent visits may all help improve compliance.

Entities:  

Year:  2002        PMID: 12354373     DOI: 10.1007/s11940-002-0014-4

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  43 in total

1.  Improving the convenience of home-based interferon beta-1a therapy for multiple sclerosis.

Authors:  J Lesaux; G Jadbäck; C E Harraghy
Journal:  J Neurosci Nurs       Date:  1999-06       Impact factor: 1.230

2.  Metered-dose inhaler adherence in a clinical trial.

Authors:  C S Rand; R A Wise; M Nides; M S Simmons; E R Bleecker; J W Kusek; V C Li; D P Tashkin
Journal:  Am Rev Respir Dis       Date:  1992-12

3.  Strategies for evaluating adherence to sleep restriction treatment for insomnia.

Authors:  B W Riedel; K L Lichstein
Journal:  Behav Res Ther       Date:  2001-02

4.  Factors related to adherence to medication regimens in pediatric seizure patients.

Authors:  A Hazzard; S J Hutchinson; N Krawiecki
Journal:  J Pediatr Psychol       Date:  1990-08

Review 5.  Tolerance and intolerance to continuous positive airway pressure.

Authors:  M Anstead; B Phillips; K Buch
Journal:  Curr Opin Pulm Med       Date:  1998-11       Impact factor: 3.155

6.  A randomised trial of strategies to improve patient compliance with anticonvulsant therapy.

Authors:  G M Peterson; S McLean; K S Millingen
Journal:  Epilepsia       Date:  1984-08       Impact factor: 5.864

7.  Compliance--a joint effort of the patient and his doctor.

Authors:  M Feuerstein; V Lieb-Jückstock; H Schnaus; E Springmann; B Weber; M Wunderlich
Journal:  Epilepsy Res Suppl       Date:  1988

8.  Compliance with antiplatelet therapy in patients with ischemic cerebrovascular disease. Assessment by platelet aggregation testing.

Authors:  T Komiya; M Kudo; T Urabe; Y Mizuno
Journal:  Stroke       Date:  1994-12       Impact factor: 7.914

9.  Compliance during treatment of epilepsy.

Authors:  I E Leppik
Journal:  Epilepsia       Date:  1988       Impact factor: 5.864

10.  Routine outpatient L-dopa monitoring in elderly patients with Parkinson's disease.

Authors:  L G Copeland; J Dutton; N B Roberts; J R Playfer
Journal:  Age Ageing       Date:  1994-03       Impact factor: 10.668

View more
  1 in total

1.  Noncompliance in neurologic patients.

Authors:  David B Weiss; Thomas P Beresford; Robert M House
Journal:  Curr Treat Options Neurol       Date:  2005-09       Impact factor: 3.972

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.